Gonadal status in patients with end stage kidney disease before and after renal transplantation

2015 ◽  
Vol 122 (03) ◽  
Author(s):  
W Reinhardt ◽  
H Kübber ◽  
S Tan ◽  
A Kribben ◽  
D Führer
Keyword(s):  
Renal Transplantation ◽  
Kidney Disease ◽  
End Stage Kidney Disease ◽  
Before And After ◽  
End Stage ◽  
Gonadal Status

scholarly journals Thiamine Diphosphate Status and Dialysis-Related Losses in End-Stage Kidney Disease Patients Treated with Hemodialysis

2017 ◽  
Vol 44 (4) ◽  
pp. 294-300 ◽  
Author(s):  
Magdalena Jankowska ◽  
Paweł Rudnicki-Velasquez ◽  
Hanna Storoniak ◽  
Przemysław Rutkowski ◽  
Bolesław Rutkowski ◽  
...  
Keyword(s):  
Body Weight ◽  
Kidney Disease ◽  
Dietary Intake ◽  
Whole Blood ◽  
Vitamin B1 ◽  
Thiamine Diphosphate ◽  
End Stage Kidney Disease ◽  
Before And After ◽  
End Stage ◽  
The Impact

Aim: (1) To describe the whole blood content of thiamine diphosphate (TDP), a biologically active form of vitamin B1 in end-stage kidney disease patients treated with hemodialysis (HD); (2) to establish the impact of a single HD procedure on TDP blood concentrations; and (3) to describe potential explanatory variables influencing TDP dialysis related losses, including dialysis prescription, vitamin B1 dietary intake and supplementation. Methods: Single-center, cross-sectional study in 50 clinically stable maintenance HD patients. The assessment of whole blood TDP with the High Performance Liquid Chromatography method, before and after a single, middle-week dialysis session and analysis of clinical and laboratory parameters potentially influencing TDP status Results: We report a significant difference in TDP levels before and after HD sessions - 42.5 (95% CI 38.7-46.2) μg/L and 23.6 (95% CI 18.9-28.2) μg/L, respectively (p = 0.000). The magnitude of intradialytic TDP changes is highly variable among individuals and is negatively associated only with the body weight of the patients (p < 0.013). Vitamin B1 dietary intake and supplementation do not influence whole blood TDP and dialysis-related loss of TDP. Conclusions: TDP, a bioactive compound of vitamin B1, is substantially lost during the HD procedure, and the magnitude of its loss is associated with the patient's body weight but it is not influenced by vitamin B1 dietary intake and standard supplementation dose.

scholarly journals Change of Hospitalization Status Among Patients With End-Stage Kidney Disease Before and After Receiving Chronic Hemodialysis

2021 ◽  
Author(s):  
Hsiu-Lan Li ◽  
Pei-Hui Tai ◽  
Yi-Ting Hwang ◽  
Shih-Wei Lin ◽  
Li-Ching Lan
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Kidney Disease ◽  
Tract Infection ◽  
Hospital Admission ◽  
End Stage Kidney Disease ◽  
Study Results ◽  
Before And After ◽  
One Year ◽  
End Stage

Abstract Background:Compared with other diseases, end-stage kidney disease (ESKD) carries a greater risk of comorbidities including diabetes and anemia and has a higher hospital admission rate. The cause of hospital admission appears to be a common factor affecting the prognosis of patients with ESKD. Therefore, this study conducted a retrospective cohort analysis on all patients diagnosed with ESKD and receiving hemodialysis, investigating whether the type of their diagnosis for hospital admission changed before and after they started hemodialysis.Methods:This study recruited 592 patients with ESKD who received hemodialysis at any period between January 2005 and November 2017 and had been assigned the International Classification of Diseases Ninth Revision Clinical Modification (ICD-9-CM) code for ESKD. The patients’ demographic data and hospitalization status one year before and two years after they received hemodialysis were analyzed. A McNemar test was conducted to analyze the diagnostic changes from before to after hemodialysis in patients with ESKD.Results:The study’s sample of patients with ESKD comprised more women (51.86%) than men and had an average age of 67.15 years. The numbers of patients admitted to hospital for the following conditions all decreased significantly after they received hemodialysis: type 2 (non-insulin-dependent and adult-onset) diabetes; native atherosclerosis; urinary tract infection; gastric ulcer without mention of hemorrhage, perforation, or obstruction; pneumonia; reflux esophagitis; duodenal ulcer without mention of hemorrhage, perforation, or obstruction; and bacteremia. Most patients exhibited one or more of the following comorbidities: diabetes (n = 407, 68.75%), hypertension (n = 491, 82.94%), congestive heart failure (n = 161, 27.20%), ischemic heart disease (n = 125, 21.11%), cerebrovascular accident (n = 93, 15.71%), and gout (n = 96, 16.22%). An analysis of variance (ANOVA) indicated that changes in the ICD-9-CM codes for native atherosclerosis, urinary tract infection, pneumonia, and hyperkalemia were associated with age. Patients who developed pneumonia before or after they received hemodialysis tended to be older (range: 69–70 years old). Conclusions:This study investigated the causes of hospital admission among patients with ESKD one year before and two years after they received hemodialysis. This study results revealed hypertension to be the most common comorbidity. Regarding cause of admission, pneumonia was more prevalent in older than in younger patients. Moreover, changes in the ICD-9-CM codes of native atherosclerosis, urinary tract infection, pneumonia, and hyperkalemia were significantly correlated with age. Therefore, when administering comprehensive nursing care and treatment for ESKD, clinicians should not focus only on comorbidities but also consider factors (e.g., age) that can affect patient prognosis.

No evidence of improvement in neuropathy after renal transplantation in patients with end stage kidney disease

2021 ◽  
Author(s):  
Maryam Ferdousi ◽  
Shazli Azmi ◽  
Alise Kalteniece ◽  
Saif Ullah Khan ◽  
Ioannis N Petropoulos ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Kidney Disease ◽  
End Stage Kidney Disease ◽  
End Stage

Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation

2017 ◽  
Vol 33 (2) ◽  
pp. 341-350 ◽  
Author(s):  
Britta Höcker ◽  
Martin Aguilar ◽  
Paul Schnitzler ◽  
Lars Pape ◽  
Luca Dello Strologo ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Kidney Disease ◽  
Vaccination Coverage ◽  
End Stage Kidney Disease ◽  
End Stage

scholarly journals Right Ventricular Functionality Following Hemodialysis Initiation in End-Stage Kidney Disease—A Single-Center, Prospective, Cohort Study

Medicina ◽  
2021 ◽  
Vol 57 (7) ◽  
pp. 704
Author(s):  
Ana Tanasa ◽  
Alexandru Burlacu ◽  
Iolanda Valentina Popa ◽  
Adrian Covic
Keyword(s):  
Kidney Disease ◽  
Right Ventricular ◽  
Speckle Tracking Echocardiography ◽  
Systolic Function ◽  
End Stage Kidney Disease ◽  
Before And After ◽  
End Stage ◽  
Post Hoc ◽  
Rv Function ◽  
Conventional Echocardiography

Background and Objectives: Two-dimensional speckle tracking echocardiography (2D-STE) is viewed as an outstanding technique, competent of uncovering earlier subclinical myocardial anomalies compared to conventional echocardiography. A few endeavors adopted 2D-STE as a tool to estimate right ventricular (RV) function in subjects with end-stage kidney disease (ESKD). There is no published prospective study on an adult ESKD cohort exploring the consequences of commencing elective hemodialysis (HD) on RV behavior. Materials and Methods: We investigated the RV systolic function using traditional (tricuspid annular plane systolic excursion—TAPSE, RV fractional area change—FAC) and 2D-STE (RV free wall longitudinal strain—RVFWLS) parameters following the initiation of HD. We enrolled 79 consecutive patients with ESKD and assessed them in four steps—at baseline, before HD, and at 3, 6, and 12 months. Results: RVFWLS, FAC, and TAPSE values had a significant increase at 3, 6, and 12 months from baseline (p < 0.001) and a significant increase at 6 months from 3 months (p < 0.001). However, differences between 12 months and 6 months were not significant (p > 0.05) according to Dunn–Bonferroni post hoc tests. Seventeen deaths were recorded before the completion of the study. RVFWLS, FAC, and TAPSE values significantly decreased at 3 and 6 months in all 17 deceased patients, in clear opposition with the values survivors had. All the studied parameters had a significant prediction power on mortality (p < 0.001) having an outstanding performance: baseline-RVFWLS (AUC: 1.000 (95% C.I.: 1.000–1.000)), baseline-FAC (AUC: 0.974 (95% C.I.: 0.942–1.000)), and baseline-TAPSE (AUC: 0.962 (95% C.I.: 0.920–1.000). Conclusions: Our study is the first to investigate RV function by 2D-STE and correlate it with traditional methods in patients with ESKD before and after the initiation of HD. RV function was significantly ameliorated at 3, 6, and 12 months compared to the pre-HD values. FAC and RVFWLS gain an outstanding prognostic role on mortality in this population.

Sign in / Sign up

Export Citation Format

Share Document